DarioHealth (NASDAQ:DRIO) Shares Pass Below 200-Day Moving Average – Should You Sell?

DarioHealth Corp. (NASDAQ:DRIO)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.80 and traded as low as $0.60. DarioHealth shares last traded at $0.66, with a volume of 354,314 shares trading hands.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. TD Cowen lowered shares of DarioHealth from a “buy” rating to a “hold” rating and dropped their price objective for the company from $2.00 to $1.00 in a research report on Wednesday, January 29th. Stifel Nicolaus decreased their target price on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th.

DarioHealth Stock Up 0.1 %

The firm has a market capitalization of $27.26 million, a price-to-earnings ratio of -0.70 and a beta of 1.42. The stock has a fifty day moving average of $0.67 and a two-hundred day moving average of $0.80. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

Institutional Investors Weigh In On DarioHealth

Several institutional investors and hedge funds have recently made changes to their positions in the stock. DLK Investment Management LLC lifted its stake in shares of DarioHealth by 40.9% in the fourth quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock worth $111,000 after acquiring an additional 41,107 shares during the period. Appian Way Asset Management LP raised its holdings in DarioHealth by 2.5% during the 3rd quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after purchasing an additional 34,990 shares during the last quarter. Finally, XTX Topco Ltd lifted its position in shares of DarioHealth by 81.4% in the 3rd quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after purchasing an additional 13,219 shares during the period. Institutional investors and hedge funds own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.